Saturday July 4, 2020

Elan suffers a bad reaction

A double dose of bad news sent the drug company’s share price into freefall.

2nd August, 2008

A double dose of bad news sent the drug company’s share price into freefall.

There was certainly a sense of deja vu for Elan in recent days, as the share price collapsed on the back of two major announcements from the company. It is three years since the stock last had a dramatic tumble and it will no doubt further enforce the view among many investors that Elan carries too much risk.

New...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 6 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago